ImmunotherapyLung Cancer

Immune Checkpoint Inhibitors Offer New Hope for Patients with Lung Cancer

Several immune checkpoint inhibitors are now approved for patients with non–small-cell lung cancer, giving hope to patients living with this disease.
November 2018 Volume 4 – Lung Cancer
Jane Morgan

Lung cancer remains the leading cause of cancer-related deaths in men and women, accounting for 1 in every 4 deaths caused by cancer in the United States. However, recent advances in immunotherapy, especially those called “immune checkpoint inhibitors,” bring new hope for patients with lung cancer.

Recommended For You
Last modified: January 4, 2019

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.